Atlas Trials

Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants

Clinical trial NCT04515628 · COMPLETED

Trial details

NCT number
NCT04515628
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2020-08-02
Primary completion
2020-10-18
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.